Pfizer decides not to break up business
Company had been talking about a split for several years, thinking that two companies might grow faster than one
Pfizer
Pfizer expects to close Medivation buyout in 3Q
Medivation focuses on developing medicines for cancer and serious diseases with few treatment options
Pfizer M&A blitz could heighten investor interest in biotechnology sector
Drug company's buying spree could be harbinger of more deals to come, according to at least one market observer
Stocks move lower in quiet trade; oil prices decline
Cancer drug maker Medivation jumped 20 percent after Pfizer announced it would buy the company for $14 billion
Pfizer buying cancer drug maker Medivation for $14B
Deal speeds Pfizer on path to be key player in cancer drug sector, its chairman and CEO says
Big drugmakers are gouging refugee children, group says
Doctors Without Borders says pneumonia vaccine in Greece costs 20 times what it does in other countries
Pfizer highlights risks of opioid painkillers
As concerns mount about addiction, pharma giant says it wants to help address public health concern
Pfizer buying Anacor Pharmaceuticals in $5.2B deal
Anacor's stock soared more than 53 percent in Monday premarket trading; deal is expected to close in the third quarter
Pfizer blocks use of its drugs for lethal injections
Human rights groups says 25 FDA-approved drugmakers have now restricted their products from being used in executions
Pfizer tops forecasts on higher sales, lower taxes
Drugmaker raised its financial forecasts, citing strong operational performance in the quarter and an improved business outlook
Shareholders give Pfizer an earful over scrapped Allergan deal
Deal was structured as an inversion, in which a U.S. company moves its headquarters on paper to another country with lower tax rates
Which stock to buy now, Pfizer or Allergan?
Actually, a good argument can be made for buying both because each company is strong with good future prospects
Pfizer's next takeover target will be American
It failed on the tax-favored Allergan deal, but it still needs to expand -- only now it will be looking closer to home
Big mergers are getting tougher to pull off
As both Pfizer-Allergan and Halliburton-Baker Hughes got government thumbs-down this week, it shows things are changing
$160 billion Pfizer-Allergan deal is dead
End of Pfizer's tax-cutting "inversion" buy of fellow drug maker would come after Obama and Treasury Dept. took aim at such agreements
Analysts: New inversion rules will kill $160B Pfizer-Allergan deal
Drugmakers scramble to figure whether to proceed with their plan to merge and move address to lower-tax Ireland
Allergan shares tumble on new tax inversion rules
Treasury's harder push against mergers that relocate U.S. firms overseas to save taxes threatens the deal with Pfizer
Drug ads: $5.2 billion annually -- and rising
Nine out 10 big pharma companies spend more on marketing than on R&D, but what are consumers getting in return?
Pfizer earnings fall but top forecasts
Company benefited from growing sales of its newest products, as well as the additional of injectable medicines made by Hospira
Drugmakers ring in 2016 with hefty price hikes
Big pharma is busily raising prices on dozens of medications, branded and generic, with increases of 20 percent or more
Hillary Clinton says no to corporate tax inversions
The Democratic presidential candidate vows to take executive action to halt the scheme that lets U.S. firms cut their taxes
Will Pfizer bring its tax bonanza back to the U.S.?
To hear CEO tell it, takeover of Allergan will free up cash to invest and hire domestically -- don't bank on it
5 things to know about the biggest ever drug merger
Pfizer and Allergan have inked a record $160 billion deal -- what does it mean for investors and consumers?
Pfizer, Allergan combining in $160 billion deal
Deal, which creates the world's biggest drugmaker, uses a highly controversial method to drastically cut Pfizer's tax tab
U.S. toughens rules in corporate tax dodges
Transactions such as mergers that result in U.S. companies relocating HQ overseas to avoid taxes just got a little harder
Senate rejects funding bills again as government shutdown continues into second week
The government shutdown stretched into its sixth day on Monday with no signs of an imminent resolution.
Illinois, Chicago sue to block Trump deployment of National Guard
The state of Illinois and city of Chicago are suing the Trump administration over their plans to deploy the National Guard.
Israel and Hamas begin indirect Gaza ceasefire talks in Egypt
President Trump wants Israeli and Hamas negotiators to "move fast" in new talks aimed at securing a ceasefire in the Gaza war, spurred by his 20-point plan.
Exclusive
Illegal crossings at U.S.-Mexico border plummet to lowest annual level since 1970
Unlawful crossings on the southern border have hit a 55-year low, according to figures obtained by CBS News — as President Trump cracks down on illegal immigration.
Air traffic controllers told to keep working during government shutdown
National Air Traffic Controllers Association tells its members that failing to report to work could cost them their job.
FBI analyzed some Republican lawmakers' phone records as part of Trump Jan. 6 probe
The FBI in 2023 analyzed phone records of more than a half dozen Republican lawmakers as part of an investigation into efforts by President Trump to overturn the results of the 2020 presidential election, GOP senators say.
U.S. to take ownership stake in Trilogy Metals, which has Alaskan mining claims
Interior Secretary Doug Burgum said the "ownership in that company will benefit the American people."
Helicopter crashes on Sacramento freeway; at least 3 critically injured
Officials are investigating after a medical helicopter crashed on a Sacramento freeway Monday evening.
Bill Nye warns U.S. could "cede leadership to other countries" if NASA budget is cut
Bill Nye the Science Guy on Monday protested against a federal budget proposal that would see NASA's funding reduced from $24 billion to $18.8 billion.